New chemo spray shows promise for hard-to-treat stomach cancer
NCT ID NCT05644249
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 32 times
Summary
This study tested a new treatment for stomach cancer that has spread to the lining of the abdomen. It combined standard IV chemotherapy with a procedure called PIPAC, which sprays chemotherapy directly into the abdomen as a mist. The goal was to see if this combination was practical and could shrink tumors. 37 people took part in this early-stage study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nationa Cancer Institute
Vilnius, Vilniaus, 08406, Lithuania
-
Vilnius University hospital Santaros Klinikos
Vilnius, Vilniaus, 08661, Lithuania
Conditions
Explore the condition pages connected to this study.